(Reuters) -U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop…
AT&T shares hit three-decade low as lead cables risk weighs
By Chibuike Oguh NEW YORK (Reuters) -Shares of AT&T Inc fell nearly 7% to hit their lowest level in thirty…
US FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies
(Reuters) -The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy…
Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals targeting a novel form of…
US FDA approves Sarepta’s gene therapy for rare muscular dystrophy in some kids
By Leroy Leo and Aditya Samal (Reuters) – The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics’ first-of-its-kind…
Analysis-Biden’s IRA climate bill won’t cut deficit as expected
By Jarrett Renshaw (Reuters) – When President Joe Biden signed his signature Inflation Reduction Act last August, he hailed the…
Amazon completes One Medical takeover after FTC nod, discounts membership
By Mrinmay Dey and Jeffrey Dastin (Reuters) -Amazon.com Inc said on Wednesday it had completed its $3.5 billion takeover of…
California pension fund asks to meet Norfolk Southern after Ohio derailment
By Isla Binnie and Simon Jessop NEW YORK (Reuters) – Major U.S. pension fund CalPERS is seeking a meeting with…
Germany’s Fresenius to simplify structure, flags potential profit fall
By Ludwig Burger FRANKFURT (Reuters) -German healthcare group Fresenius SE will slash costs and proceed with plans to cede strategic…
Novartis names Firmenich CEO as chairman designate of Sandoz
ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis…